Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study

for the RADIANCE Trial Investigators

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences